ULTRAGENYX EUROPE GMBH
502078-5456InactiveAdvancing transformative medicines for rare and ultra-rare genetic diseases globally.
Biopharmaceutical Companyultragenyx.com
Översikt
- 1–4
- Anställda
- Okänt
- Omsättning
- 2022
- Grundat
Nyckelbeslutsfattare
Emil D. Kakkis
Chief Executive Officer and President
Beskrivning
Ultragenyx is a dedicated biopharmaceutical company focused on transforming the lives of individuals living with rare and ultra-rare genetic diseases. The organization commits itself daily to the development and delivery of novel treatments where none currently exist. They achieve this by exploring...
Taggar
B2BB2C
Nyckelord
Biopharma